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Coronary 64-slice CT angiography predicts
outcome in patients with known or suspected
coronary artery disease
Abstract The aim of this study was to
assess the prognostic value of 64-slice
CT angiography (CTA) in patients
with known or suspected coronary
artery disease (CAD). Sixty-four-slice
coronary CTA was performed in 220
patients [mean age 63±11 years, 77
(35%) female] with known or sus-
pected CAD. CTA images were ana-
lyzed with regard to the presence and
number of coronary lesions. Patients
were followed-up for the occurrence
of the following clinical endpoints:
death, nonfatal myocardial infarction,
unstable angina, and coronary revas-
cularization. During a mean follow-up
of 14±4 months, 59 patients (27%)
reached at least one of the predefined
clinical endpoints. Patients with ab-
normal coronary arteries on CTA (i.e.,
presence of coronary plaques) had a
1st-year event rate of 34%, whereas in
patients with normal coronary arteries
no events occurred (event rate, 0%,
p<0.001). Similarly, obstructive
lesions (≥50% luminal narrowing) on
CTAwere associated with a high first-
year event rate (59%) compared to
patients without stenoses (3%,
p<0.001). The presence of obstructive
lesions was a significant independent
predictor of an adverse cardiac out-
come. Sixty-four-slice CTA predicts
cardiac events in patients with known
or suspected CAD. Conversely,
patients with normal coronary arteries
on CTA have an excellent mid-term
prognosis.
Keywords Sixty-four-slice CT
angiography . Coronary artery
disease . Prognosis
Abbreviations CT: computed
tomography . CTA: CT angiography .
CA: coronary angiography . CAD:
coronary artery disease . SPECT:
single photon emission computed
tomography . CCS: coronary calcium
score
Introduction
The advent of multislice computed tomography (CT)
technology, including short gantry rotation times and
submillimeter spatial resolution, has provided clinicians
with a new promising tool for the noninvasive coronary
artery assessment. Several reports have documented the
excellent diagnostic accuracy of multislice CTangiography
(CTA) compared to conventional coronary angiography
(CA) in multiple populations [1–4], suggesting a potential
role of CTA as an alternative first-line imaging modality in
the diagnosis of patients with suspected coronary artery
disease (CAD) [5, 6].
However, as with most emerging techniques, the prog-
nostic value of CTA has not been elucidated yet. Never-
theless, in patients with known or suspected CAD,
assessment of prognosis is crucial, and a considerable
part of therapeutic decisions is based upon this knowledge.
In CAD assessment, a large number of diagnostic tools,
particularly imaging techniques, has proved to provide
prognostic information that may aid to stratify patients into
high-risk or low-risk categories. For example, coronary
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artery calcium assessed with electron beam or multislice
CT is known to provide an estimate of coronary athero-
sclerosis and has proven to correlate closely with the
occurrence of long-term coronary events and cardiac death
[7–10]. Similarly, a normal myocardial perfusion single
photon emission computed tomography (SPECT) is
associated with a low risk of cardiac events (<1% per
year) even when angiographic CAD is present, whereas the
risk in patients with abnormal SPECT is significantly
higher [11]. Conventional CA provides a variety of
information used for risk stratification of stable patients.
Patients with three-vessel disease on CA have an
approximately twofold higher 12-year mortality than
patients with one-vessel disease, and the presence of left
main disease is an important negative predictor [12].
Additionally, left ventricular angiography provides an
estimate of systolic function and helps to determine
which patients are at higher risk and should receive more
aggressive treatment [12, 13].
Intuitively, it seems that conventional CA and CTA may
deliver similar prognostic information, both being angio-
graphic techniques. However, in addition to assessing
coronary luminology, CTA has the potential of visualizing
coronary artery wall morphology, thereby identifying and
characterizing non-stenotic plaques that may often remain
undetected by routine angiographic procedures. Previous
reports have suggested that assessment of non-stenotic
coronary plaques may allow for improved cardiovascular
risk stratification [14, 15], but the prognostic value of these
findings has not been sufficiently investigated yet [16].
Therefore, the aim of the present study was to assess the
prognostic value of 64-slice CTA in a population with
known or suspected CAD.
Materials and methods
Study population
The study population consisted of consecutive patients
with known or suspected CAD undergoing further testing
in our institution as part of their diagnostic workup
(conventional CA, myocardial perfusion imaging, stress
electrocardiography). Reasons for patient’s referral to
further testing were typical or atypical chest pain, patho-
logical exercise test, dyspnea, unexplained syncope, or
preoperative cardiac risk evaluation. Patients were eligible
for CTA if they were in stable clinical condition, i.e., if they
were in Canadian Cardiac Society class I to III, and in New
York Heart Association functional class I to III, had normal
renal function, regular sinus rhythm, and no contra-
indications to iodinated contrast agents. Patients with
coronary artery bypass grafts were excluded. The study
protocol was approved by the local institutional review
board, and written informed consent was obtained from all
subjects before enrollment.
After enrollment and prior to CT image acquisition,
patients were questioned by a physician regarding their
cardiac history, symptoms, cardiovascular risk factors, and
current medication. Preexisting CAD was defined by
previous angiographical evidence (on conventional CA)
of coronary stenoses >50%. A history of myocardial
infarction was defined on the basis of typical chest pain
symptoms, typical electrocardiographic changes and/or
elevated cardiac enzyme levels as recommended by the
European Society of Cardiology [17]. Anginal pain was
defined as dull, strangling or constricting retrosternal pain
with irradiation to neck, left arm, or abdomen provoked by
exertion and relieved by rest or nitrates (typical) or
occurring regardless of physical activity (atypical). Non-
anginal chest pain lacked the characteristic qualities
described above [13]. Obesity was defined as a body
mass index >30 kg/m2; diabetes mellitus as a fasting
glucose level ≥7.0 mmol/l (126 mg/dl) or the need for
insulin treatment or oral antidiabetic agents; hypercholes-
terolemia as a total cholesterol level ≥5.0 mmol/l (195 mg/
dl) or current treatment with lipid-lowering drugs; arterial
hypertension as a blood pressure ≥140/90 mm Hg or
current treatment with antihypertensive medication.
CTA image acquisition
Electrocardiographically (ECG) gated CTAwas performed
using 64-slice CT systems (GE Lightspeed VCT, GE
Healthcare, Milwaukee, WI, or Siemens Somatom Sensa-
tion 64, Siemens Medical Solutions, Forchheim, Ger-
many). The CT scans were performed according to
standard scanning parameters provided by either type of
scanner and recommended by the manufacturer and have
been described in detail elsewhere [18–20]. First, a
prospectively gated low-dose sequential CT scan of the
heart was run for coronary artery calcium detection and
quantification [19]. Thereafter, a contrast-enhanced retro-
spectively gated spiral CT scan was performed covering the
distance from the tracheal bifurcation to the diaphragm
during a single inspiratory breath hold (6 to 10 s) using
prespecified scan parameters [1, 18–21]. The arrival of
contrast material in the coronary arteries was timed using
either an automated bolus tracking approach or an
additional timing bolus sequence as previously reported
[1, 18, 19, 21]. Depending on the total scan time, 80 to
135 ml nonionic iodinated contrast material (Visipaque
320, 320 mg/ml; GE Healthcare, Buckinghamshire, UK, or
Ultravist 370, 370 mg/ml, Schering AG, Berlin, Germany)
was injected into an antecubital vein with a flow rate of
5 ml/s followed by a saline chaser bolus. Patients with pre-
scan heart rates above 70 beats per minute (bpm) received
intravenous beta-blocker therapy (5 to 15 mg metoprolol
tartrate, Lopresor, Daiichi Sankyo, Switzerland) immedi-
ately prior to the CT scan if no contraindications were
present. Additionally, sublingual isosorbiddinitrate 2.5 mg
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(Isoket, Schwarz Pharma AG, Munchenstein, Switzerland)
for coronary dilatation was administered to every patient
prior to the scan.
ECG-pulsing for radiation dose reduction was used in all
patients. Synchronized to ECG, CT data sets were retro-
spectively reconstructed in mid- to end-diastolic phases
and additional phases if needed for optimal coronary artery
visualization. The reconstruction parameters for slice
thickness, field of view, and convolution kernel have
been described previously and are in keeping with standard
clinical practice [18, 19, 21]. For post-processing and
image interpretation, the images were then transferred to an
external designated workstation (Advantage Workstation,
GE, or Leonardo, Siemens).
Coronary calcium score
The coronary calcium score (CCS) was determined using
the SmartScore software package (GE Healthcare, Mil-
waukee, WI). Coronary artery lesions were manually
planimetered by a single experienced observer. The total
calcium burden in the coronary arteries was quantified
based on the scoring algorithm of Agatston et al. [22],
where coronary calcifications were defined as a lesion with
an area greater than 1 mm2 and a peak intensity greater than
130 Hounsfield units (HU). CCS was determined for the
four main coronary arteries in all slices and summed to
generate the total score.
CTA image interpretation
CTA image interpretation was performed on axial source
images, multiplanar and curved reformations, and thin-slab
maximum intensity projections. First, coronary arteries
were subdivided into 17-segments according to a modified
model proposed by the American Heart Association [23].
Each coronary segment was visually evaluated by two
independent experienced readers with regard to the
presence of coronary plaques, plaque morphology and
constitution, and coronary stenoses. In cases of disagree-
ment between both readers, a joint reading was performed
and consensus reached. CTA findings were not made
available to clinicians and, therefore, not implemented in
decision making.
Initially, image quality and interpretability were as-
sessed, and each coronary segment was rated evaluable or
nonevaluable. Segments were rated non-evaluable if severe
motion artifacts prevented reliable evaluation of the vessel
wall and lumen or if intracoronary stents were present as
the stent strut artifacts prevent assessment of plaque
morphology. Patients were excluded if one or more
proximal segments or more than three segments overall
were nonevaluable. Only segments with a diameter
>1.5 mm were included in the analysis.
Assessment of CT coronary plaques
Both readers independently evaluated every segment with
regard to the presence of coronary plaques. For plaque
analysis and tissue differentiation, the optimal image
display setting was chosen on an individual basis, in
general at a window between 600 and 900 HU and at a
level between 40 and 250 HU [14, 24]. Plaque analysis was
performed on longitudinal sections of straight multiplanar
reconstructions (along the vessel center-line) and axial
cross-sections (perpendicular to the vessel center-line) with
a thickness of 1 mm using the Coronary Vessel Analysis
protocol of the CardIQ Xpress software on a Advantage
Workstation 4.3 (GE Healthcare, Milwaukee, WI) (Fig. 1).
Coronary plaques were defined as structures ≥1 mm2
(visible in at least one of the cross-sections) within and/or
adjacent to the coronary artery lumen, which can be clearly
distinguished from the vessel lumen and the surrounding
tissue. The composition of the plaque was characterized
based on the presence of calcified (structures with densities
above the adjacent vessel lumen) and non-calcified
elements (structures with densities below the adjacent
vessel lumen) as follows [3, 24]: (1) non-calcified plaques
(lower CT density than the contrast-enhanced vessel-
lumen and/or no coronary calcium on CCS scan, (2)
mixed plaques (noncalcified and calcified elements
within the plaque, calcified elements occupying <50%
of the total plaque), and (3) calcified plaques (calcified
elements occupying ≥50% of the total plaque). For
each patient, the number of affected segments and the
location and composition of coronary plaques were
recorded. Patients without coronary calcium on CCS
scans and without evidence of coronary plaques on CTA
were considered to have normal coronary arteries.
Assessment of CT coronary stenoses
For assessment of obstructive lesions, all the segments with
plaques were visually evaluated on at least two image
planes, one parallel (longitudinal sections) and one
perpendicular (axial sections) to the vessel center-line as
described above. The axial cross-sections were recon-
structed with a thickness of 3 mm using the Coronary
Vessel Analysis protocol of the CardIQ Xpress software on
a Advantage Workstation 4.3 (GE Healthcare, Milwaukee,
WI) [24]. For coronary stenoses analysis, the minimal
luminal diameter of the stenotic segment was visually
compared to the adjacent proximal and distal nonstenotic
reference segment with regard to coronary luminal
narrowing. A coronary plaque was considered to be
obstructive if the minimal luminal diameter was less than
50% of the adjacent reference diameter in either the
longitudinal section or one of the cross-sections (Fig. 1).
For every patient, the number and location of obstructive
lesions was recorded.
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Follow-up data
Follow-up data were obtained from clinical visits and/or
telephone calls to patients and their physicians. Clinical
endpoints were (1) death from any cause, (2) cardiac death,
(3) non-fatal myocardial infarction, (4) unstable angina
requiring hospitalization, and (5) coronary revasculariza-
tion [percutaneous coronary intervention (PCI) or coronary
artery bypass surgery (CABG)]. Cardiac death was defined
as death from myocardial infarction, cardiac arrhythmia,
refractory heart failure, or cardiogenic shock. Nonfatal
myocardial infarction was defined as described above [17].
Data interpretation and statistical analysis
Follow-up data were analyzed by obtaining cumulative
event rates using the Kaplan-Meier function. Event-free
survival curves were plotted for a composite endpoint of
death, myocardial infarction, unstable angina, and coronary
revascularization and compared using the log-rank test. To
assess the influence of CTA findings on clinical endpoints,
univariate Cox regression analysis was used. Additionally,
multivariate Cox regression was applied to identify inde-
pendent predictors by including all factors with p<0.05 and
correction for the baseline characteristics with p<0.1 on
univariate analysis. The regression results are presented as
hazard ratios (HR) and their respective confidence intervals
(CI). Receiver-operating characteristics (ROC) analysis
was applied to determine the optimal cut-off for the number
of coronary plaques, and stenoses that predicted cardiac
events and sensitivity, specificity, positive (PPV) and
negative predictive value (NPV) were subsequently
calculated based upon that cut-off.
Statistical analysis was performed using the SPSS
software package (SPSS 12.0.1 for Windows, SPPS
Corp., Chicago, IL) and the MedCalc statistical software
(MedCalc 9.0.1.1 for Windows, Medcalc Software,
Mariakerke, Belgium). Quantitative data are expressed as
means±SD and compared using a two-tailed unpaired
Student’s t test. Categorical data are given in proportions or
percentages and compared by a chi-squared test. A p-value
<0.05 was considered statistically significant for all tests.
Results
From February 2005 until June 2006, a total of 223 patients
who met the inclusion criteria gave written informed
consent. Three patients (1%) had to be excluded due to
a b
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Fig. 1 Visual assessment of a right coronary artery plaque with
regard to coronary plaques (a) and coronary stenoses (b) on
multiplanar reformations. For coronary plaque analysis (a) cross-
sections (1–8) were reconstructed with a thickness of 1 mm. The
longitudinal vessel section and the corresponding cross-section
show a mixed plaque with calcified and non-calcified elements. For
coronary stenosis analysis (b), cross-sections were reconstructed
with a thickness of 3 mm. Comparison of the minimal luminal
diameter with adjacent vessel segments yields a high-grade (≥50%)
stenosis
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insufficient CTA image quality. In the remaining 220
patients follow-up data were recorded, and none of the
patients was lost to follow-up.
The mean age of the study population was 63±11 years
(range, 38 to 89 years), and 77 patients (35%) were female.
Thirty-seven patients (17%) had known CAD at the time of
CTA, and 24 patients (11%) had a history of myocardial
infarction. The complete clinical characteristics are given
in Table 1.
CT findings
In 220 patients a total of 3,031 coronary segments was
evaluated. After excluding 53 (1.7%) segments due to
insufficient image quality or intracoronary stents, plaque
burden and composition were assessed in 2,978 segments.
Coronary plaques were found in 839 segments (28%)
corresponding to 177 patients (80%). Of these plaques, 28
(3%) were noncalcified, 223 (27%) mixed and 588 (70%)
calcified. Obstructive lesions were identified in 251
segments (8%) corresponding to 95 patients (43%). The
mean Agatston score was 507±833 (range, 0 to 6,690).
According to the CT findings, 40 patients (18%) had
coronary one-vessel disease, 39 patients (18%) two-vessel
disease, and 16 patients (7%) three-vessel disease. In 43
patients (20%), normal coronary arteries without radiolog-
ical evidence for coronary plaques were found. All
coronary segments in patients with normal coronary
arteries were evaluable. A left dominant coronary distri-
bution type was found in 20 patients (9%). The exact
distribution and properties of coronary plaques among
patients with or without cardiac events on follow-up are
shown in Table 2.
Table 1 Clinical characteristics of the study population
All patients (n=220) Patients with events (n=59) Patients without events (n=161) p
Age (years) 63±11 65±8 62±11 0.02
Gender (female) 77 (35%) 17 (29%) 60 (37%) 0.24
BMI (kg/m2) 27±4 27±5 26±4 0.15
Cardiac history (n)
Known CAD 37 (17%) 18 (31%) 19 (12%) 0.001
Previous MI 24 (11%) 13 (22%) 11 (7%) 0.001
Previous PCI 33 (15%) 17 (29%) 16 (10%) <0.001
Symptoms (n)
No complaints 78 (35%) 11 (17%) 67 (42%) 0.002
Non-anginal chest pain 18 (8%) 2 (3%) 16 (10%) 0.12
Atypical angina 48 (22%) 16 (27%) 32 (20%) 0.25
Typical angina 42 (19%) 22 (37%) 20 (12%) <0.001
Dyspnea 34 (15%) 8 (14%) 26 (16%) 0.64
Cardiovascular risk factors (n)
Obesity 37 (17%) 13 (22%) 24 (15%) 0.21
Diabetes mellitus 34 (15%) 15 (25%) 19 (12%) 0.01
Hypercholesterolemia 106 (48%) 36 (61%) 70 (43%) 0.02
Arterial hypertension 138 (63%) 45 (76%) 93 (58%) 0.009
Current smoking 82 (37%) 31 (53%) 51 (32%) 0.005
Current medication (n)
ACEI/ARB 98 (45%) 34 (58%) 64 (40%) 0.02
Nitrates 9 (4%) 2 (3%) 7 (4%) 0.75
Beta-receptor antagonists 107 (49%) 42 (71%) 65 (40%) <0.001
Aspirin 145 (66%) 52 (88%) 93 (58%) <0.001
Statins 78 (35%) 28 (47%) 50 (31%) 0.02
Data not shown as n (%) are mean±SD. BMI, body mass index; CAD, coronary artery disease; ACEI/ARB, angiotensin-converting enzyme
inhibitors/angiotensin receptor blockers. p-value is given for comparison of patients with events versus patients without events
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Results of follow-up
During a mean follow-up of 14±4 months (range, 3 to
24 months), 59 patients (27%) reached at least one of the
predefined endpoints. Four deaths (2%) occurred during
follow-up, none of which was cardiac [septicemia (n=1),
aspiration pneumonia (n=1), graft infection (n=1), and
hematologic neoplasia (n=1)]. Three patients (1%) suf-
fered myocardial infarction, and two patients (1%) unstable
angina requiring hospitalization. In 58 patients (26%) a
revascularization procedure was performed [CABG (n=16),
PCI (n=43)]. Table 3 summarizes the results of follow-up in
the study population. If revascularizations were excluded,
patients with abnormal CTA had more hard cardiac events
(myocardial infarction, unstable angina) [5 (3%)] compared
to patients with normal CTA [0 (0%); p=0.30].
Survival analysis
Figures 2 to 4 show the Kaplan-Meier event-free survival
curves. Patients with normal coronary arteries on CT (no
coronary plaques or stenoses present) had an excellent
event-free survival compared to those with abnormal
coronary arteries (Fig. 2). None of the patients with normal
coronary arteries on CTA suffered a cardiac event during
follow-up. First-year event rates were 34% and 0% for
patients with abnormal and normal coronary arteries,
respectively.
Patients with obstructive lesions had significantly more
cardiac events during follow-up compared to patients
without obstructive lesions (Fig. 3). First-year event rates
were 59% and 3% for patients with and without obstructive
lesions on CTA, respectively.
Table 2 CT findings
All patients (n=220) Patients with events (n=59) Patients without events (n=161) p
Total calcium score* 507±833 886±900 376±769 <0.001
Coronary plaques 177 (80%) 59 (100%) 118 (73%) <0.001
Plaques in LMA/LAD 163 (74%) 57 (97%) 106 (66%) <0.001
Plaques in LMA 65 (30%) 24 (41%) 41 (25%) 0.03
Plaques in LAD 160 (73%) 57 (97%) 103 (64%) <0.001
Plaques in LCX 121 (55%) 51 (86%) 70 (43%) <0.001
Plaques in RCA 116 (53%) 48 (81%) 68 (42%) <0.001
Plaques in proximal segments† 163 (74%) 56 (95%) 107 (66%) <0.001
Distal plaques only‡ 14 (6%) 3 (5%) 11 (7%) 0.64
Segments with plaques 3.8±3.3 6.3±2.8 2.9±2.9 <0.001
Noncalcified plaques 0.1±0.4 0.3±0.5 0.1±0.4 0.006
Mixed plaques 1.0±1.5 2.2±1.9 0.6±1.1 <0.001
Calcified plaques 2.7±2.6 3.9±2.7 2.2±2.4 <0.001
Nonobstructive plaques only 82 (37%) 3 (5%) 79 (49%) <0.001
Coronary stenoses 95 (43%) 56 (95%) 39 (24%) <0.001
Stenoses in LMA/LAD 76 (35%) 47 (80%) 29 (18%) <0.001
Stenoses in LMA 5 (2%) 3 (5%) 2 (1%) 0.09
Stenoses in LAD 73 (33%) 46 (78%) 27 (17%) <0.001
Stenoses in LCX 41 (19%) 27 (49%) 14 (9%) <0.001
Stenoses in RCA 44 (20%) 28 (47%) 16 (19%) <0.001
Stenoses in proximal segments† 75 (34%) 41 (69%) 34 (21%) <0.001
Distal stenoses only‡ 20 (9%) 15 (25%) 5 (3%) <0.001
Segments with stenoses 1.1±1.7 2.7±1.9 0.6±1.3 <0.001
One-vessel disease 40 (18%) 20 (34%) 20 (12%) <0.001
Two-vessel disease 39 (18%) 24 (41%) 15 (9%) <0.001
Three-vessel disease 16 (7%) 12 (20%) 4 (2%) <0.001
Left dominance 20 (9%) 8 (14%) 12 (7%) 0.16
Data not shown as n (%) are mean±SD. *Calcium score is given as Agatston score. †Proximal segments include the LMA and the proximal
segments of LAD, LCX, and RCA. ‡Distal segments comprise all segments not included as proximal segments. LMA, left main artery;
LAD, left anterior descending artery; LCX, left circumflex artery; RCA, right coronary artery; p-value is given for comparison of patients
with events versus patients without events
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When comparing patients with normal coronary arteries,
non-obstructive plaques and obstructive lesions on CTA,
the highest event rates were noted in the latter group, while
event rates were lower yet slightly elevated in patients with
non-obstructive plaques (Fig. 4).
Predictors of outcome
The results of univariate Cox regression analysis applied
for clinical characteristics, symptoms, cardiovascular risk
factors, and CT findings are shown in Table 4. Advanced
age, history of CAD, and history of MI were associated
with an increased incidence of cardiac events. The patient’s
symptoms were not found to predict cardiac events during
follow-up except for typical angina (p<0.001). Further-
more, the traditional cardiovascular risk factors showed a
weak, but significant association with a worse outcome
except for obesity, which was not a significant predictor of
events.
Conversely, the presence of coronary atherosclerosis as
evidenced by coronary plaques on CT was a strong
predictor of cardiac events [HR, 30.05 (95% CI, 2.15–
420.07); p=0.011]. Other significant predictors were the
presence of plaques in the LMA or LAD, the presence of
plaques in any of the proximal segments of the three main
coronary arteries, and the number of segments with
plaques. Patients with coronary stenoses on CTA were at
significantly higher risk for cardiac events on follow-up
[HR, 35.22 (95% CI, 11.00–112.81); p<0.001], particu-
larly if stenoses were located in the LMA or in the LAD.
Further univariate predictors for cardiac events were the
number of segments with stenoses and the number of
vessels with stenoses (p<0.001). Multivariate Cox regres-
sion analysis identified the presence of obstructive coronary
plaques on CTA as an independent predictor of cardiac
events [HR, 12.65 (95% CI, 2.59–61.72); p=0.002].
ROC curves plotted for the number of coronary plaques
and the number of coronary stenoses on CTA revealed an
optimal cut-off at ≥3 coronary plaques and ≥1 coronary
0 5 10 15 20 25
Follow-up (months)
0.0
0.2
0.4
0.6
0.8
1.0
Ev
en
t-f
re
e 
su
rv
iv
al
Normal coronary arteries
Abnormal coronary arteries
p<0.001 (log rank test)
Fig. 2 Kaplan-Meier analysis
for event-free survival in pa-
tients with normal or abnormal
coronaries on CTA
Table 3 Follow-up results
All patients
(n=220)
Patients with
plaques (n=177)
Patients without
plaques (n=43)
p Patients with
stenoses (n=95)
Patients without
stenoses (n=125)
p
Any cardiac event 59 (27%) 59 (33%) 0 (0%) <0.001 56 (59%) 3 (2%) <0.001
All-cause mortality 4 (2%) 3 (2%) 1 (2%) 0.78 1 (1%) 3 (2%) 0.46
Myocardial infarction 3 (1%) 3 (2%) 0 (0%) 0.39 2 (2%) 1 (1%) 0.41
Unstable angina requir-
ing hospitalization
2 (1%) 2 (1%) 0 (0%) 0.48 2 (2%) 0 (0%) 0.10
Revascularization 58 (26%) 58 (33%) 0 (0%) <0.001 55 (58%) 3 (2%) <0.001
CABG 16 (7%) 16 (9%) 0 (0%) 0.04 16 (17%) 0 (0%) <0.001
PCI 43 (20%) 43 (24%) 0 (0%) <0.001 40 (42%) 3 (2%) <0.001
Data are shown as n (%). CABG, coronary artery bypass surgery; PCI, percutaneous coronary intervention
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stenoses providing the highest diagnostic accuracy for the
prediction of cardiac events on follow-up (for ≥3 coronary
plaques: sensitivity 93%, specificity 57%, PPV 38%, NPV
99%; for ≥1 coronary stenosis: sensitivity 90%, specificity
76%, PPV 51%, NPV 96%) (Fig. 5).
Discussion
In the present study, CTA provided prognostic information
in patients with known or suspected CAD. Patients with no
evidence of coronary atherosclerosis on CTA had an
excellent mid-term prognosis, and no cardiac events
occurred in this group. The risk for cardiac events,
however, increased significantly if coronary plaques or
obstructive coronary lesions were present (1st-year event
rates, 34% and 59%, respectively). There was a strong
positive correlation between the extent of coronary
atherosclerosis (i.e., the number of segments with coronary
plaques) and an adverse cardiac outcome. Interestingly, the
strongest association was found for coronary lesions in the
LMA or LAD or in proximal segments of any of the three
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Fig. 3 Kaplan-Meier curves for
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main vessels. The presence of three or more coronary
plaques was the cut-off providing the highest accuracy to
predict future cardiac events.
Our results are well in line with previously published
data by Pundziute and coworkers [16] analyzing 100
patients with 16- and 64-slice CT. In this population the
1st-year event rate for patients with abnormal coronary
arteries was 30% compared to 0% in patients with normal
coronary arteries. These results support the notion, that not
only obstructive lesions, but also non-obstructive plaques
may play an important role in cardiac risk calculations and
emphasize the importance of noninvasive tools for the
evaluation of coronary plaque burden.
It is well established that coronary stenoses as evidenced
by angiographic techniques are associated with an adverse
outcome depending on their location and amount [12, 13],
even more so if stenoses are associated with myocardial
underperfusion as assessed by myocardial perfusion imag-
ing [11]. However, fatal cardiac events may arise from
rupture of vulnerable non-stenotic plaques that remain
undetected by clinical evaluation or routine angiographic
procedures [25, 26]. To date, visualization of non-stenotic
plaques is cumbersome, and the existing technology,
among others intravascular ultrasound [27], plaque ther-
mography [28], optical coherence tomography [29], and
angioscopy [30], is invasive and not suitable for routine
clinical use. Multislice high-resolution CTA has been
introduced as a rapid noninvasive tool for the assessment of
coronary arteries, evaluating both the coronary lumen and
vessel wall and providing information not only on coronary
stenoses, but also on non-stenotic plaques.
The present study showed a high cardiac event rate in
patients with obstructive lesions. Nevertheless, an elevated
event rate was also observed in patients with coronary
Table 4 Univariate predictors
of cardiac events
HR, hazard ratio; CI, confidence
interval; CAD, coronary artery
disease; MI, myocardial infarc-
tion; PCI, percutaneous coro-
nary intervention; LMA, left
main artery; LAD, left anterior
descending artery
HR (95% CI) p
Clinical characteristics
Age, years 1.03 (1.00–1.05) 0.02
Female gender 1.36 (0.78–2.40) 0.28
History of CAD 2.71 (1.55–4.73) <0.001
Previous MI 3.07 (1.65–5.70) <0.001
Symptoms
No complaints 0.37 (0.19–0.72) 0.003
Non-anginal chest pain 0.37 (0.09–1.52) 0.17
Atypical angina 1.46 (0.82–2.59) 0.20
Typical angina 3.10 (1.82–5.27) <0.001
Dyspnea 0.75 (0.34–1.65) 0.47
Cardiovascular risk profile
Obesity 1.50 (0.81–2.79) 0.20
Diabetes mellitus 2.11 (1.17–3.79) 0.013
Hypercholesterolemia 1.76 (1.04–2.98) 0.036
Arterial hypertension 2.22 (1.20–4.11) 0.011
Current smoking 2.17 (1.30–3.64) 0.003
CT findings
Calcium score 1.00 (1.00–1.01) <0.001
Presence of coronary plaques 30.05 (2.15–420.07) 0.011
Plaques in LMA/LAD 11.55 (2.82–47.34) 0.001
Plaques in proximal segments 7.50 (2.34–23.97) 0.001
Plaques in distal segments only 0.80 (0.25–2.54) 0.70
Segments with plaques 1.28 (1.19–1.37) <0.001
Segments with noncalcified plaques 1.71 (1.14–2.56) 0.009
Segments with mixed plaques 1.57 (1.38–1.79) <0.001
Segments with calcified plaques 1.21 (1.11–1.32) <0.001
Presence of coronary stenoses 35.22 (11.00–112.81) <0.001
Stenoses in LMA/LAD 10.45 (5.52–19.80) <0.001
Segments with stenoses 1.41 (1.29–1.54) <0.001
Number of vessels with stenoses 2.57 (2.05–3.22) <0.001
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plaques regardless whether obstructive or non-obstructive.
This observation may provide a rationale for a more
aggressive risk modification in patients with non-stenotic
coronary plaques. However, further studies are needed to
investigate a potential benefit of aggressive risk modifica-
tion in patients with non-stenotic coronary plaques as
evidenced by CTA.
The management of patients with suspected or known
CAD is largely based on initial clinical evaluation, with the
low-risk patients being reassured and the high-risk patients
referred for invasive CA. Unfortunately, a significant
number of patients belong to an intermediate risk category
where prognosis and management are less well defined. In
these patients further diagnostic workup with noninvasive
techniques is needed to narrow down each patient’s
individual risk profile and guide further management
decisions. The detection of considerable myocardial ische-
mia by stress echocardiography or myocardial perfusion
imaging is associated with a high short- to mid-term
cardiovascular risk and warrants aggressive treatment and
coronary revascularization [31]. On the other hand, the
presence of atherosclerotic coronary plaques as assessed
with calcium scoring by electron-beam or multislice CT is
an important predictor of long-term cardiovascular events.
Similarly, in our study, the presence of obstructive coronary
lesions was associated with the highest risk for cardiac
events. Nevertheless, the risk was also slightly elevated for
non-obstructive coronary plaques, and the presence of
three or more coronary plaques appears to represent the
best cut-off above which the mid-term risk of cardiac
events is increased. In the future, this cut-off may provide a
simple tool for clinicians to stratify patients to low- or high-
risk categories and guide further risk management
decisions. Most importantly, however, a 100% event-free
survival was noted in patients with normal coronary
arteries on CTA. This finding is clinically relevant since
patients with normal coronary arteries can be safely
reassured of a good prognosis.
Study limitations
An important drawback of the present study was the
relatively short follow-up interval and the limited number
of patients. As a result, the higher incidence of cardiac
events in the group with abnormal coronary arteries on
CTA was largely driven by a high amount of revascular-
ization procedures. It seems that the follow-up time was too
short for enough hard cardiac events, such as myocardial
infarction and cardiac death, to happen. Nonetheless, more
hard cardiac events occurred in the group with abnormal
coronary arteries compared to those with normal CT
findings (3% versus 0%), and larger studies are needed to
confirm these results.
The study population was heterogeneous and consisted
of patients with suspected and known CAD, including
patients with a history of myocardial infarction and
previous PCI. Accordingly, treatment strategies may have
varied considerably across the study population depending
on the patients’ clinical characteristics. Further studies
must be conducted to evaluate the prognostic role of CTA
in more homogeneous populations.
Conclusion
Our study results demonstrate that 64-slice CTA provides
prognostic information in patients with suspected or known
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Fig. 5 Receiver-operating characteristics (ROC) curves. ROC curve
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CAD. The highest rate of cardiac events was noted in
patients with obstructive coronary lesions. Nevertheless,
patients with coronary plaques on CTA were also
associated with an elevated risk for future cardiac events.
Most importantly, however, a 100% event-free survival
was present in patients with normal coronary arteries, thus
reassuring these patients and avoiding further testing.
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